We previously revealed that downregulated 4.1N/EPB41L1 exerts antitumor effects by activating the classical Wnt pathway and C-MYC expression in NSCLC (Wang et al., 2016; Yang et al., 2016; Yang et al., 2021). This evidence concerns the gene MYC and non-small cell lung carcinoma.